Cyclacel Pharmaceuticals, Inc.
Records under this name other than the patents Cyclacel Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 6 of 6 · Back to Cyclacel Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,133,199 | Pyrimidine derivatives as protein kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,563,542 | Pyrimidine derivatives as protein kinase inhibitors Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 6,403,555 | Depsipeptide and congeners thereof for use as immunosuppressants Formerly held Term ended Term ended Dec 6, 2020 · From the USPTO record | Term ended | Term ended Dec 6, 2020 | From the USPTO record |
| US 6,548,479 | Depsipeptide and Congeners Thereof for Use as Immunosuppressants Formerly held Term ended Term ended Dec 6, 2020 · Medium confidence | Term ended | Term ended Dec 6, 2020 | Medium confidence |
| US 6,828,302 | Therapeutic Uses of Depsipeptides and Congeners Thereof Formerly held Term ended Ended no later than Dec 6, 2020 · Low confidence | Term ended | Ended no later than Dec 6, 2020 | Low confidence |
| US 7,041,639 | Depsipeptide and Congeners Thereof for Use as Immunosuppressants Formerly held Lapsed on the fee record Ended May 9, 2018 · Medium confidence | Lapsed on the fee record | Ended May 9, 2018 | Medium confidence |